Over 41,000 bottles of Walgreens nasal spray have been recalled due to bacterial contamination that could cause serious health complications, raising fresh concerns about product safety oversight in America’s pharmaceutical supply chain.
Story Highlights
- FDA recalls 41,328 bottles of Walgreens Saline Nasal Spray with Xylitol over pseudomonas lactis contamination.
- Class II recall issued for products with lot numbers 71409 and 71861, sold nationwide at Walgreens stores.
- Bacterial contamination could cause temporary or medically reversible adverse health consequences.
- Walgreens offers full refunds for affected products as authorities investigate contamination source.
FDA Issues Nationwide Product Recall
The Food and Drug Administration announced in November 2025 a voluntary recall of 41,328 bottles of Walgreens Saline Nasal Spray with Xylitol due to potential contamination with pseudomonas lactis bacteria. The recall specifically targets 1.5-ounce bottles from two production lots distributed across Walgreens locations nationwide. This bacterial strain, commonly found in raw milk, poses significant health risks when introduced into nasal passages through contaminated medical products.
💊 CHECK YOUR CABINET: The FDA announced a recall of 41,000+ bottles of Walgreens Saline Nasal Spray with Xylitol over possible bacterial contamination.https://t.co/vHsbLtvj3F
— Fox News (@FoxNews) November 25, 2025
Specific Products and Risk Assessment
Two specific lot numbers are affected by this recall: Lot No. 71409 expiring February 28, 2027, and Lot No. 71861 expiring August 31, 2027. The FDA classified this as a Class II recall, indicating exposure could cause temporary or medically reversible adverse health consequences. While authorities note the probability of serious adverse health consequences remains remote, the classification represents the second-highest risk level in FDA recall classifications.
Corporate Response and Consumer Safety
Walgreens responded swiftly to the FDA guidance, with company representatives emphasizing customer safety as their top priority. The retailer instructed consumers to immediately discontinue use of affected products and return them to any store location for full refunds. However, authorities have not disclosed how the contamination occurred, raising questions about quality control processes in the pharmaceutical supply chain that could affect American families seeking basic healthcare products.
Health Implications During Flu Season
This recall comes as the CDC recommends flu vaccination for all individuals six months and older, particularly those at higher risk of serious complications. The timing proves especially concerning as families rely on over-the-counter nasal sprays during peak cold and flu season. Contaminated nasal products present unique risks since they deliver bacteria directly to mucous membranes, potentially causing infections in users seeking relief from common respiratory ailments.
